Litcius/Paper detail

MicroRNAs involved in the TGF-β signaling pathway in atherosclerosis

Xiaoqing Li, Jinyu Wang, Cheng Wu, Xiang Lu, Jingjing Huang

2021Biomedicine & Pharmacotherapy21 citationsDOIOpen Access PDF

Abstract

Atherosclerosis (AS) is a chronic inflammatory vascular disease with a multifactorial pathogenesis. It becomes a global health concern, especially causing an array of fatal consequences among the elderly. However, the mechanisms of AS remain unexplained. The transforming growth factor-β (TGF-β) signaling pathway is widely involved in the inflammation, immune function, proliferation, differentiation,and apoptosis in vivo. Based on previous researches, it has not been confirmed whether the TGF-β pathway promotes or inhibits atherosclerosis. Furthermore, more and more studies have found that microRNAs can regulate atherosclerosis through the TGF-β signaling pathway. In this review, we summarize and discuss the role of microRNAs in the pathogenesis of atherosclerosis via the TGF-β signaling pathway.

Topics & Concepts

microRNASignal transductionTransforming growth factorCancer researchCell biologyMedicineBiologyGeneticsGeneBiomarkers in Disease MechanismsAtherosclerosis and Cardiovascular DiseasesMicroRNA in disease regulation